Buprenorphine Transdermal Patch: An...
This agent may be an alternative for patients with pain severe enough to require around-the-clock, long-term opioid therapy when other optio...
Read More
Cognitive Impairment and Dementia in Type...
Through screening for early detection of cognitive impairment and dementia, patients have a better chance of managing their diabetes at hom...
Read More
New Changes in Pregnancy and Lactation...
The proposed rule will replace existing regulations and provide detailed, current information for patients and their providers.
Read More
New Drug Review 2014
This article reviews five new drugs (umeclidinium and vilanterol, vortioxetine, dapagliflozin, luliconazole, sofosbuvir) that were approved ...
Read More
Review of Selected NMEs 2014
Five new molecular entities (riociguat, ibrutinib, obinutuzumab, coagulation factor XIII A-subunit [recombinant], collagenase clostridium hi...
Read More
Contribution to Breast Cancer Prevention...
New guidelines recommend chemoprevention (tamoxifen or raloxifene) for high-risk patients.
Read More
Gender Differences in Pharmacokinetics
Women are underrepresented and gender-specific analysis is uncommon in most clinical trials.
Read More
Advertisement
 U.S. Pharmacist Digital Edition
Become a fan on Facebook Follow us on Twitter
Advertisement
In This Issue

FDA Review Designations for New Molecular Entities 10/16/2014

The FDA is expanding its efforts to expedite the development and review of ...

Academic Detailing: Accurate, Relevant, Balanced, and Engaging 10/16/2014

Educating clinicians through academic detailing is an effective way ...

Review of Selected NMEs 2014 10/16/2014

Five new molecular entities (riociguat, ibrutinib, obinutuzumab, coagulation ...

Buprenorphine Transdermal Patch: An Overview for Use in Chronic Pain 10/16/2014

This agent may be an alternative for patients with pain severe enough to ...

Purple Book Introduced for Biosimilars 10/16/2014




Continuing Education

Off-Label Drug Use and Promotion

2.00 Credits, Expires: 10/31/2016 **Payment is required for exam to be graded.

Management of Menopausal Symptoms

2.00 Credits, Expires: 9/30/2016 **Payment is required for exam to be graded.

Review of Nonneurogenic Overactive Bladder

2.00 Credits, Expires: 8/30/2016 **Payment is required for exam to be graded.

Electronic Cigarettes: Potential Risks and Benefits

2.00 Credits, Expires: 7/31/2016 **Payment is required for exam to be graded.
Popular Articles
Advertisement
Quick Poll

The DEA recently launched a program that allows consumers to return unused controlled substances to pharmacies. Do you think this is a good idea?



Vote!     View Results


Web Only Articles